Jen Cheng Lin

Introduction

Jen Cheng Lin is an innovative inventor based in Keelung, Taiwan, known for her contributions in the field of pharmaceutical sciences. With a total of two patents to her name, she has made significant advancements in the modulation of PPARγ expression and the enhancement of anti-platelet drug delivery for treating acute stroke.

Latest Patents

Jen Cheng Lin's latest patents include:

1. **Compounds for enhancing PPARγ expression and nuclear translocation and therapeutic use thereof** - This invention introduces a novel type of PPARγ modulator characterized by a pyrimido[5,4-d]pyrimidine main structure. It has been designed to enhance the expression and nuclear translocation of PPARγ in cells. The patent also covers a pharmaceutical composition that encapsulates this modulator within a cell-penetrating drug delivery system, enabling direct cellular delivery. This invention is intended to provide a method for preventing or treating PPARγ-related disorders through the administration of a therapeutically effective amount of the modulator or its pharmaceutical composition.

2. **Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke** - This invention outlines a method for improving the delivery of anti-platelet drugs aimed at treating acute stroke. By using a composition that includes an anti-platelet drug alongside a vehicle that reduces plasma protein binding rates, the invention allows for effective treatment at lower doses. This method not only minimizes potential side effects associated with high dosages but also enhances the targeted delivery of anti-platelet drugs to the site of treatment.

Career Highlights

Jen Cheng Lin is currently affiliated with Realinn Life Science Limited, where she continues to develop innovative pharmaceutical solutions. Her work focuses on creating advanced therapies that address critical healthcare needs through targeted drug delivery and modulation mechanisms.

Collaborations

Throughout her career, Jen has teamed up with talented coworkers, including Chun-Chieh Lin and Yu-Ming Fan, fostering a collaborative environment that enhances research productivity and innovation.

Conclusion

Jen Cheng Lin stands out as a remarkable inventor whose contributions enhance the therapeutic landscape, particularly in the fields of metabolic disorders and acute stroke treatment. Her patents reflect a commitment to improving patient outcomes through scientific innovation, making her a valuable asset to the life sciences community.